Cemiplimab, a Human PD-1 Monoclonal Antibody, Versus Chemotherapy in First-Line Treatment of Advanced NSCLC with PD-L1 >= 50%

Sezer A., Gogishvili M., Bentsion D., Kilickap S., Lowczak A., Gumus M., ...More

JOURNAL OF THORACIC ONCOLOGY, vol.14, no.10, 2019 (SCI-Expanded, Scopus)

• Publication Type: Article / Abstract
• Volume: 14 Issue: 10
• Publication Date: 2019
• Doi Number: 10.1016/j.jtho.2019.08.1345
• Journal Name: JOURNAL OF THORACIC ONCOLOGY
• Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
• Open Archive Collection: AVESIS Open Access Collection
• Hacettepe University Affiliated: Yes